Spitalul Clinic Cf Nr.2 Bucuresti

At Spitalul Clinic Cf Nr.2 Bucuresti in Bucharest, the Oncology portfolio focuses on neoplasms and includes studies aimed at improving treatment options for people with advanced or recurrent cancer. The research is centered on finding more effective ways to maintain disease control and extend progression-free survival.

• Advanced or recurrent endometrial cancer
• Testing a new maintenance therapy for TP53WT disease
• Comparing treatment benefit against placebo to assess disease control

These trials are designed to evaluate whether new cancer therapies can better delay progression and support longer-lasting outcomes for patients with difficult-to-treat gynecologic malignancies.

The site is also conducting research in early breast cancer, with a strong focus on patients who have a higher risk of recurrence. This work examines how well a targeted endocrine approach may improve invasive breast cancer-free survival compared with standard care.

• Node-positive, estrogen receptor-positive, HER2-negative early breast cancer
• Evaluating a treatment strategy to reduce recurrence risk
• Comparing a new option with standard endocrine therapy

This line of research aims to refine long-term treatment decisions for patients with hormone-sensitive breast cancer and improve protection against disease return.

Clinical trials at this hospital also cover immune system diseases, especially moderate to severe plaque psoriasis. The main goal is to better understand the long-term safety of newer immune-targeted treatments and how they compare with established options.

• Plaque psoriasis with moderate-to-severe symptoms
• Assessing cardiovascular safety during long-term treatment
• Comparing a newer therapy with ustekinumab

This research supports safer, more informed treatment choices for chronic inflammatory skin disease by looking at both effectiveness and overall patient safety.